Mater Research
- Company typePrivate
- Founded1910
- HeadquartersSouth Brisbane, Australia
- Headcount51–100
- GTM typeB2B
- OfferingServices
Mater Research firmographics
Firmographics- Name
- Mater Research
- Legal name
- Mater Misericordiae Ltd
- Website
- https://materresearch.org.au
- Company type
- Private
- Founded year
- 1910
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Mater Research industry classification
Industry- Product category
- Medical Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
Keywords
Where Mater Research is headquartered
LocationHeadquarters
- HQ city
- South Brisbane
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Mater Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Government Research Grants: Primary funding from competitive government grants including NHMRC (National Health and Medical Research Council), MRFF (Medical Research Future Fund), and CRC-P (Cooperative Research Centres Projects) grants
- Philanthropic Funding: Funding from Mater Foundation, Equity Trustees partnership program, and other charitable donors supporting research programs and researcher career development
- Clinical Trials Revenue: Revenue from conducting industry-sponsored and investigator-initiated clinical trials through Mater Clinical Trials unit
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Mater Research product offering
Product offeringCore offering
Mater Research is a translational medical research institute conducting biomedical and clinical research across five core programs: Cancer, Mother and Baby, Chronic and Integrated Care, Neuroscience, and Healthcare Delivery and Innovation. The institute operates clinical trials, longitudinal cohort studies, biobanks, and develops diagnostic platforms such as the AI-powered RhinoMAP. Research findings are translated into improved patient care at affiliated Mater hospitals and disseminated through peer-reviewed publications and clinical guidelines.
Product overview
Mater Research is a translational medical research institute operating as part of the Mater Group. The organization conducts research across five core programs: Cancer, Mother and Baby, Chronic and Integrated Care, Neuroscience, and Healthcare Delivery and Innovation. Research activities span diagnostic platforms (RhinoMAP), longitudinal cohort studies (Queensland Family Cohort, Strong Families Study), clinical trials, and digital health services (eConsultant). The institute maintains specialized biobanking infrastructure and partners with clinical services to translate discoveries into patient care.
Differentiator
Problem solved
Functional benefit
Products and services
- RhinoMAP
- Strong Families Study
- Queensland Family Cohort (QFC)
- Mater Clinical Trials
- Mater Research Biobank
- Inflammatory Bowel Disease Biobank
- eConsultant Program
Quantifiable outcome
- Reduced stillbirth rates through Safer Baby SEEK program implementation
- +3 more outcomes
Companies that use Mater Research
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Mater Research technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
Mater Research partnerships and signals
Strategic signalPartnerships
20 partnerships are on record, tiered core, major and supporting.
- Monash UniversitycoreCollaborating partner in CRC-P project for respiratory disease AI diagnostic platform (RhinoMAP), contributing to clinical validation and research expertise
- Diag-Nose.iocoreAustralian health technology company leading development of AI-powered diagnostic platform for respiratory diseases, partnered with Mater Research for clinical validation
- ENT Clinic MelbournemajorClinical partner providing otolaryngology expertise for respiratory disease diagnostic platform validation
- Manse MedicalmajorMedical technology partner contributing to respiratory disease diagnostic platform development
- InvetechsupportingTechnology partner involved in diagnostic platform development and manufacturing
- Human HealthsupportingPartner in respiratory disease AI diagnostic project
- The University of QueenslandcoreMajor academic partner; UQ representation on Mater Research Board; Mater Clinical Unit at UQ; joint research programs and publications
- Translational Research Institute (TRI)coreCollaborative research institute partnership; Mater secured 5 of 10 TRI LINC Grants in 2025
- Health Translation QueenslandmajorBrisbane-wide collaborative network evolved from Diamantina Health Partners Mother and Baby Program
- Indigenous Steering Committeecore32 representatives from partner health services across Cairns, Mareeba, Townsville, Rockhampton, and Brisbane leading co-designed Indigenous health research
- Carbal Aboriginal Medical ServicescoreCommunity-controlled health service in Toowoomba and Warwick co-designing research with Indigenous Health Group
- Harvard Medical SchoolmajorInternational research collaborator on OTUD3 gene discovery for ulcerative colitis
- Mass General BrighammajorUS collaborator on IBD genetic research; Dr Manish Gala co-author on OTUD3 study
- Monash UniversitymajorAustralian collaborator on ulcerative colitis genetic research study
- University of CopenhagenmajorInternational research partner on COVID-19 GPR183 antagonism treatment research
- Australasian Leukaemia Lymphoma GroupcoreCollaborative partner for Phase I immunotherapy clinical trial for EBV-associated Diffuse large B-cell lymphoma
- Stellenbosch UniversitymajorSouth African university where Prof Ronacher holds appointment as Extraordinary Associate Professor; ongoing TB research collaboration
- 32 Indigenous Health ServicescoreRepresentatives from partner health services across Queensland forming Indigenous Steering Committee for Strong Families Study
- International Association of Diabetes in Pregnancy Study GroupsmajorGlobal organization where E/Prof McIntyre was founding member establishing GDM diagnostic criteria
- Aarhus UniversitymajorDanish institution where E/Prof McIntyre serves as Honorary Skou Professor and Danish Diabetes Academy Visiting Professor
Scale indicators16 records
Recent moves6 records
Expansion highlights6 records
Mater Research competitors and assessment
Company assessmentDirect peers
- Telethon Kids Institute: Western Australian child health research institute with a strong Aboriginal health research program. Mater Research's Indigenous health co-design approach and child/maternal research focus are directly comparable.
- Garvan Institute of Medical Research: Sydney-based medical research institute with programs in cancer, diabetes, neuroscience, and genomics. Mater's diabetes-in-pregnancy research (McIntyre) and neuroscience program are directly comparable to Garvan's clinical-translational focus areas.
- Children's Medical Research Institute: Sydney-based institute focused on children's health, cancer, and genetic disease research. Mater Research's mother-and-baby health focus and longitudinal cohort research are comparable in translational pediatric research orientation.
- Centenary Institute: Sydney-based medical research institute focused on cancer, cardiovascular disease, and immunology. Comparable in scale and translational research orientation, and similarly reliant on NHMRC/MRFF funding and university-hospital partnerships.
- Harry Perkins Institute of Medical Research: Western Australian medical research institute focused on cancer, cardiovascular disease, and diabetes. Comparable mid-sized translational institute competing for NHMRC funding with overlapping disease-area focus.
- Walter and Eliza Hall Institute of Medical Research (WEHI): Australia's oldest medical research institute, focused on cancer, immunology, and infectious disease with a strong discovery-to-clinic pipeline. Mater Research is comparable in research program breadth (cancer, immunology, chronic disease) and competes for the same national competitive grant funding and biotech partnerships.
- South Australian Health and Medical Research Institute (SAHMRI): Adelaide-based flagship medical research institute with programs in cancer, heart health, and Aboriginal health. Mater Research's Indigenous health co-design model and translational research orientation make SAHMRI a comparable peer competing for the same national funding streams.
- Hudson Institute of Medical Research: Melbourne-based translational medical research institute covering cancer, reproductive health, and chronic disease. Mater Research is comparable in its translational model (co-located with hospital) and in its mother-and-baby and cancer research program mix.
- Baker Heart and Diabetes Institute: Melbourne-based institute dedicated to cardiovascular and diabetes research. Mater Research's diabetes-in-pregnancy program and chronic disease research make this a directly comparable peer in scope and translational focus.
- QIMR Berghofer Medical Research Institute: Queensland's largest medical research institute, also focused on translational biomedical research across cancer, infectious disease, and mental health. Mater Research operates in the same Brisbane-based translational medical research category and competes for the same NHMRC/MRFF funding pool and clinical trial sponsors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Mater Research social profiles
Digital presenceMater Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mater Research leadership team
Management profileNumber of profiles
Profiles4 records
Mater Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mater Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mater Research
What does Mater Research do?
Mater Research is a translational medical research institute conducting biomedical and clinical research across five core programs: Cancer, Mother and Baby, Chronic and Integrated Care, Neuroscience, and Healthcare Delivery and Innovation. The institute operates clinical trials, longitudinal cohort studies, biobanks, and develops diagnostic platforms such as the AI-powered RhinoMAP. Research findings are translated into improved patient care at affiliated Mater hospitals and disseminated through peer-reviewed publications and clinical guidelines.
Is Mater Research a public or private company?
Mater Research is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Mater Research founded?
Mater Research was founded in 1910. It employs 51 to 100 people.
Where is Mater Research based?
Mater Research is headquartered in South Brisbane, Australia, in the Oceania region.
How does Mater Research make money?
Three revenue lines are on record. Government Research Grants are the primary driver. The others are philanthropic Funding and clinical Trials Revenue.
Who are Mater Research's main competitors?
Direct peers on record are Telethon Kids Institute, Garvan Institute of Medical Research, Children's Medical Research Institute, Centenary Institute, Harry Perkins Institute of Medical Research, Walter and Eliza Hall Institute of Medical Research (WEHI), South Australian Health and Medical Research Institute (SAHMRI), Hudson Institute of Medical Research, Baker Heart and Diabetes Institute and QIMR Berghofer Medical Research Institute.
Does Mater Research have an API?
No public API is recorded for Mater Research.
What industry is Mater Research in?
Mater Research's product category is Medical Research Services. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based). Its NAICS code is 541714 and its SIC code is 8731.